Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bruckner

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Khirurgiia|November 1, 1972
[Reconstruction of the ligaments of the knee joint]H Bruckner, H Bruckner
Science (New York, N.Y.)|December 10, 1976
Antitumor drug interactions: additional dataS Waxman, H Bruckner
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|September 18, 2001
Adjuvant and neoadjuvant therapies of pancreatic cancer: a reviewJ Harris, H Bruckner
European Journal of Cancer & Clinical Oncology|July 1, 1982
The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherolS Waxman, H Bruckner
European Journal of Cancer|August 1, 1980
Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductaseH Bruckner, M Rubinoff, S Waxman
JAMA|May 23, 1977
Thiotepa, cutaneous reactions, and efficacyE M Greenspan, I Jaffrey, H Bruckner
Radiation Research|October 1, 1971
Reduced production of spleen colonies and granulocytes in antibiotic-treated irradiated mice transplanted with syngeneic bone marrowH D Preisler, H Bruckner, E S Henderson
Urology|August 1, 1982
Mycosis fungoides causing ureteral obstructionB Seidman, H Schiff, H Bruckner, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinomaN J Petrelli, Y M Rustum, H Bruckner, et al.
Cancer|August 5, 2000
Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trialH Snady, H Bruckner, A Cooperman, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Khirurgiia|November 1, 1972
[Reconstruction of the ligaments of the knee joint]H Bruckner, H Bruckner
Science (New York, N.Y.)|December 10, 1976
Antitumor drug interactions: additional dataS Waxman, H Bruckner
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|September 18, 2001
Adjuvant and neoadjuvant therapies of pancreatic cancer: a reviewJ Harris, H Bruckner
European Journal of Cancer & Clinical Oncology|July 1, 1982
The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherolS Waxman, H Bruckner
European Journal of Cancer|August 1, 1980
Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductaseH Bruckner, M Rubinoff, S Waxman
JAMA|May 23, 1977
Thiotepa, cutaneous reactions, and efficacyE M Greenspan, I Jaffrey, H Bruckner
Radiation Research|October 1, 1971
Reduced production of spleen colonies and granulocytes in antibiotic-treated irradiated mice transplanted with syngeneic bone marrowH D Preisler, H Bruckner, E S Henderson
Urology|August 1, 1982
Mycosis fungoides causing ureteral obstructionB Seidman, H Schiff, H Bruckner, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinomaN J Petrelli, Y M Rustum, H Bruckner, et al.
Cancer|August 5, 2000
Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trialH Snady, H Bruckner, A Cooperman, et al.
Pageof 3